Overview
WhiteOak Capital Pharma and Healthcare Fund Direct Growth
WhiteOak Capital Mutual Fund
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Investments in WhiteOak Capital Pharma and Healthcare Fund Direct Growth are subject to market risks. Please read the offer document carefully before investing to understand the potential market risks and rewards.
Latest NAV
₹ 13.05
Fund Size (AUM)
₹303.62 Cr
Risk
Very High (Risk rating: 6/10)
Minimum Investment
Lumpsum: ₹ 500
SIP: ₹100
Launch Date
06-Feb-2024
Expense Ratio
0.55%
Exit Load
Exit load of 1%, if redeemed within 1 months.
Benchmark
BSE Healthcare Total Return Index
Standard Deviation
N/A
History
Performance & Ratios
1-Year SIP Return
14.23%
3-Year SIP Return
N/A
5-Year SIP Return
N/A
Mean Return
N/A
Alpha
-
Beta
-
Sharpe Ratio
-
Sortino Ratio
-
Information Ratio
-
Returns
| 1Y | 3Y | 5Y | All Time | |
|---|---|---|---|---|
| Fund Returns | 31.29% | N/A | N/A | N/A |
| Category Average | 19.46% | 17.92% | 21.75% | N/A |
| Rank Within Category | 2 | N/A | N/A | N/A |
Holdings (52)
| Company | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 11.3% |
| Cipla Ltd. | Healthcare | Equity | 7.39% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 6.08% |
| Lupin Ltd. | Healthcare | Equity | 5.58% |
| Max Healthcare Institute Ltd. | Healthcare | Equity | 5.14% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 3.91% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | Equity | 3.85% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 3.81% |
| Laurus Labs Ltd. | Healthcare | Equity | 3.54% |
| Piramal Pharma Ltd. | Healthcare | Equity | 2.72% |
Holdings Analysis
Peer Comparison
SIP, STP & SWP Details
Systematic Investment Plan (SIP):
Frequency: Monthly
Min Amount: ₹ 100
Multiplier: 1
Systematic Transfer Plan (STP):
Frequency: MONTHLY
Dates: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
Min Amount: ₹ 1000
Min Installments: 6
Systematic Withdrawal Plan (SWP):
Frequency: MONTHLY
Dates: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
Min Amount: ₹ 500
Min Installments: 2
AMC Details
Asset Management Company
WhiteOak Capital Mutual Fund
None WhiteOak Capital Mutual Fund employs robust strategies to manage market risks, but investments remain subject to market risks. Please read the fund’s documentation for detailed risk management policies.
Launch Date
2018-07-03T00:00:00.560Z
Total AUM
₹ 17916.72 Cr
Address
Unit No. B4, 6th Floor,Cnergy, Appasaheb Marathe Marg,Prabhadevi Mumbai 400025
Phone
180030003060
Website
Sub Type
Contra
Sub Type Info
Contra funds follow Contrarian strategy which means investing in stocks in contrast to the prevailing sentiment. Minimum investment in equity is 65%.
Tax Impact
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Stamp Duty
0.005% (from July 1st, 2020)
Fund Manager Details
Compare with Another Fund
WhiteOak Capital Pharma and Healthcare Fund Direct Growth
WhiteOak Capital Mutual Fund
You May Be Interested In
Tata Nifty200 Alpha 30 Index Fund Direct Growth
Large & MidCap
ICICI Prudential Dividend Yield Equity Fund Direct Growth
Thematic
ICICI Prudential Nifty LargeMidcap 250 Index Fund Direct Growth
Large & MidCap
Tata Nifty India Tourism Index Fund Direct Growth
Thematic
Tata Multicap Fund Direct Growth
Multi Cap
Groww Nifty 200 ETF FoF Direct Growth
Large & MidCap
Bandhan Nifty 500 Momentum 50 Index Fund Direct Growth
Flexi Cap
Motilal Oswal Nifty Capital Market Index Fund Direct Growth
Thematic
JM Small Cap Fund Direct Growth
Small Cap
Axis Nifty500 Momentum 50 Index Fund Direct Growth
Flexi Cap
Explore More Mutual Funds
Debt Mutual Funds - Best Debt Fund Options
Discover top debt mutual funds for stable returns. Filter by NAV, fund size, and AMC to find the best debt funds for you.
Hybrid Mutual Funds - Top Hybrid Funds
Find top hybrid mutual funds for balanced growth. Filter by NAV, fund size, and risk to choose the best hybrid funds.
Commodities Mutual Funds
Explore commodities mutual funds for diversification. Filter by NAV and fund size to find the best commodity funds.
ELSS Mutual Funds - Top Tax-Saving Funds
Discover top ELSS mutual funds for tax savings and growth. Filter by NAV, fund size, and AMC to find the best ELSS funds.
Frequently Asked Questions
How is the overall rating calculated?
The overall rating for WhiteOak Capital Pharma and Healthcare Fund Direct Growth is an aggregate score based on performance metrics (returns over 1, 3, and 5 years), risk-adjusted returns (Sharpe and Sortino ratios), and consistency relative to its category. Ratings are on a scale of 1 to 5, with 5 being the highest.
What are the top stocks of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
The top stocks held by WhiteOak Capital Pharma and Healthcare Fund Direct Growth include Sun Pharmaceutical Industries Ltd., Cipla Ltd., Divi's Laboratories Ltd..
Which industries does WhiteOak Capital Pharma and Healthcare Fund Direct Growth invest in?
WhiteOak Capital Pharma and Healthcare Fund Direct Growth primarily invests in the following industries: Healthcare, Financial, Chemicals.
Who are the fund managers of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
The fund managers of WhiteOak Capital Pharma and Healthcare Fund Direct Growth are Piyush Baranwal and Ashish Agrawal and Ramesh Mantri and Dheeresh Pathak.
How many years has the fund manager been managing WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
Piyush Baranwal:
Calculating...
Ashish Agrawal:
Calculating...
Ramesh Mantri:
Calculating...
Dheeresh Pathak:
Calculating...
What is the minimum investment for WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
The minimum investment for WhiteOak Capital Pharma and Healthcare Fund Direct Growth is ₹500 for lumpsum investments and ₹100 for SIPs.
What are the average 1-year returns for WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
Calculating...
What are the average 3-year returns for WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
Calculating...
What is the expense ratio of WhiteOak Capital Pharma and Healthcare Fund Direct Growth, and how does it compare to its category?
The expense ratio of WhiteOak Capital Pharma and Healthcare Fund Direct Growth is 0.55%. No category comparison data is available.